Leeni Mäkelä, Kaija Lammintausta. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Acute DiseaseCyclooxygenase 2 Inhibitors/adverse effectsDrug Eruptions/diagnosisDrug Eruptions/etiologyDrug Eruptions/pathologyDrug Hypersensitivity/diagnosisDrug Hypersensitivity/pathologyEtoricoxibExanthema/chemically inducedExanthema/pathologyHumansMaleMiddle AgedPatch TestsPyridines/adverse effectsSkin/pathologySkin Diseases, Vesiculobullous/chemically inducedSkin Diseases, Vesiculobullous/pathologySulfones/adverse effects
Substances: See more » Cyclooxygenase 2 InhibitorsPyridinesSulfonesEtoricoxib
Year: 2008 PMID: 18311467 DOI: 10.2340/00015555-0381
Source DB: PubMed Journal: Acta Derm Venereol ISSN: 0001-5555 Impact factor: 4.437